Emerging role of microRNA 628-5p as a novel biomarker for cancer and other diseases
Open Access
- 1 October 2019
- journal article
- review article
- Published by SAGE Publications in Tumor Biology
- Vol. 41 (10)
Abstract
MicroRNAs are a family of small, single-stranded RNAs that have key roles in regulating multiple signaling pathways within a cell. Studies have implicated aberrant expression of microRNAs in the development and progression of several pathologies including cancer. MicroRNAs are relatively stable and readily available in body fluids and tissues, making them desirable biomarkers for prognostic and diagnostic purposes in an array of diseases. MicroRNA 628 (5p/3p variants) is located in the 15q21.3 cancer-related region, and evidence suggests its association with various pathologies. The -5p mature variant, microRNA 628-5p, has been reported to be differentially expressed in various cancers, and its expression has been mostly associated with tumor suppression but there are few reports identifying its role in cancer progression. Several studies have also suggested its utility in diagnosis and prognosis of various cancers. Dysregulation of microRNA 628-5p has also been implicated in embryonal implantation defects, autism, immune modulation, myogenesis, cardiovascular disease, viral infection, and skeletal muscle repair. Here, we have provided a comprehensive review on available literature explaining the role of microRNA 628-5p as a potential cancer biomarker as well as briefly describe its function in other diseases and normal physiological conditions.Keywords
Funding Information
- National Institutes of Health (R01MD012767)
- National Institutes of Health (U01CA194730)
- National Institutes of Health (U54MD012392)
This publication has 53 references indexed in Scilit:
- Profiling of MicroRNA in Human and Mouse ES and iPS Cells Reveals Overlapping but Distinct MicroRNA Expression PatternsPLOS ONE, 2013
- MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease ControlsClinical Cancer Research, 2013
- miRNA Profiles as a Predictor of Chemoresponsiveness in Wilms’ Tumor BlastemaPLOS ONE, 2013
- Differential Expression of miRNAs in Colorectal Cancer: Comparison of Paired Tumor Tissue and Adjacent Normal Mucosa Using High-Throughput SequencingPLOS ONE, 2012
- miR-590-5p, miR-219-5p, miR-15b and miR-628-5p are commonly regulated by IL-3, GM-CSF and G-CSF in acute myeloid leukemiaLeukemia Research, 2012
- Single-Nucleotide Polymorphisms Inside MicroRNA Target Sites Influence Tumor SusceptibilityCancer Research, 2010
- MicroRNA function in cancer: oncogene or a tumor suppressor?Cancer and Metastasis Reviews, 2009
- MiRNAs and CancerThe American Journal of Pathology, 2009
- Most mammalian mRNAs are conserved targets of microRNAsGenome Research, 2008
- HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemiaBlood, 2005